Cite
HARVARD Citation
Cohen, M. et al. (2021). BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS. Multiple sclerosis. pp. 1556-1563. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cohen, M. et al. (2021). BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS. Multiple sclerosis. pp. 1556-1563. [Online].